Projects per year
Personal profile
Biography
Dr James Shaw is the Director of Education and Training in Cardiology at The Alfred, and has held this position since 2014.
He is an interventional cardiologist with a specific interest in the pathophysiology of atherosclerosis both in the coronary and non coronary vascular beds. He is involved in inpatient and outpatient care and partakes in the transthoracic and transoesophageal echocardiogram reporting roster. He is a visiting cardiologist to Sandringham Hospital and to the Bairnsdale Regional health service where he provides outpatient services on a regular basis.
Following completion of his cardiology training in 1997, he undertook a PhD under the supervision of Professor Dart at the Baker Heart and Diabetes Institute and his thesis titled “Mechanisms of Plaque Stability in Coronary Artery Disease” was successfully completed in 2001. Following this he spent 2.5 years at Massachusetts General Hospital and the Brigham and Womens Hospital in Boston completing further clinical and research training in coronary and non coronary interventional work.
In 2004 he returned to Melbourne where he helped establish The Alfred Minimally Invasive Vascular Centre which focuses on endovascular intervention for non coronary atherosclerotic disease. The research interests of Dr Shaw’s group are aligned to the clinical interests and involve active collaboration between various laboratories in the Baker Institute and the clinical department of The Alfred.
He has successfully supervised students in their B Med Science and BSci (hons) projects and is actively involved in registrar supervision and training as well as helping train interventional cardiology fellows many of whom have gone on to gain senior positions.
Dr Shaw has published over 50 peer reviewed manuscripts and has been the Principal Investigator in numerous clinical trials in including the IMPROVE-IT, COMPASS and the ODYSSEY Outcomes studies.
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Research area keywords
- Pathophysiology
- Cardiology
- Atherosclerosis
Network
-
NOX5 in circulating peripheral blood mononuclear cells as a new biomarkerfor unstable diabetic cardiovascular disease
Block, T., Jandeleit-Dahm, K., Shaw, J. & Cooper, M.
1/01/22 → 31/12/22
Project: Research
-
A Phase 3, multicentre, double-blind, randomized, placebo-controlled, parallel-group study to investigate the efficacy and safety of CSL 112 in subjects with Acute Coronary Syndrome protocol #: CSL 112_3001 (the ApoA-1 Event ReducinG in Ischaemic Syndromes II (AEGIS-II) Study.
1/10/18 → 1/10/24
Project: Research
-
Nox5 as a potential biomarker for cardiovascular disease including in diabetes
1/01/17 → 31/12/18
Project: Research
-
Effects of lignocaine vs. opioids on antiplatelet activity of ticagrelor: The LOCAL trial
Fernando, H., Duong, T., Huynh, K., Noonan, J., Shaw, J., Duffy, S. J., Nehme, Z., Smith, K., Myles, P. S., Meikle, P. J., Peter, K. & Stub, D., 14 Oct 2021, In: European Heart Journal. 42, 39, p. 4025-4036 12 p.Research output: Contribution to journal › Article › Research › peer-review
Open Access4 Citations (Scopus) -
Nox5 in circulating peripheral blood mononuclear cells: a potential biomarker in unstable diabetic vascular and renal disease
Block, T., Sourris, K. C., Khan, A. W., Kantharidis, P., Jha, J. C., Cooper, M. E., Shaw, J. A. & Jandeleit-Dahm, K. A. M., 2021, In: Diabetologia. 64, p. s87-s88 2 p.Research output: Contribution to journal › Meeting Abstract › Other › peer-review
Open Access -
The opioid-P2Y12 inhibitor interaction: Potential strategies to mitigate the interaction and consideration of alternative analgesic agents in myocardial infarction
Fernando, H., Shaw, J. A., Myles, P. S., Peter, K. & Stub, D., Jan 2021, In: Pharmacology and Therapeutics. 217, 14 p., 107665.Research output: Contribution to journal › Review Article › Research › peer-review
4 Citations (Scopus) -
Antithrombotic Therapy in Myocardial Infarction: Historic Perils and Current Challenges-A 70-Year Journey
Fernando, H., McFadyen, J. D., Palasubramaniam, J., Shaw, J., Wang, X., Stub, D. & Peter, K., Oct 2020, In: Thrombosis and Haemostasis. 120, 10, p. 1352-1356 5 p.Research output: Contribution to journal › Review Article › Research › peer-review
Open Access2 Citations (Scopus) -
Incidence and risk factors for stroke following percutaneous coronary intervention
Dawson, L. P., Cole, J. A., Lancefield, T. F., Ajani, A. E., Andrianopoulos, N., Thrift, A. G., Clark, D. J., Brennan, A. L., Freeman, M., O'Brien, J., Sebastian, M., Chan, W., Shaw, J. A., Dinh, D., Reid, C. M., Duffy, S. J. & on behalf of the Melbourne Interventional Group (MIG), 1 Oct 2020, In: International Journal of Stroke. 15, 8, p. 909-922 14 p.Research output: Contribution to journal › Article › Research › peer-review
2 Citations (Scopus)